to experience the full functionality of mail.com.
Science & Technology
February 25, 2020
Drugmaker Mallinckrodt reaches $1.6B opioid settlement
The generic drugmaker Mallinckrodt has a tentative $1.6 billion deal to settle lawsuits over its role in the U.S.
In order to enable essential services and functionality on our site and to collect data on how visitors interact with our site, products and services we use tools such as cookies.